Pharma-Bio Serv (OTCMKTS:PBSV) Issues Quarterly Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSV) posted its earnings results on Monday. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02), Zacks reports. Pharma-Bio Serv had a negative net margin of 0.86% and a negative return on equity of 0.66%. The business had revenue of $2.70 billion for the quarter, compared to analysts’ expectations of $2.50 billion.

Pharma-Bio Serv Stock Up 15.3%

Shares of PBSV stock opened at $0.57 on Tuesday. The firm has a market cap of $12.94 million, a price-to-earnings ratio of -56.50 and a beta of 0.64. Pharma-Bio Serv has a 52-week low of $0.43 and a 52-week high of $1.36. The company’s 50 day moving average is $0.53 and its 200 day moving average is $0.54.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.